Page 10 - Universidade De Sao Paulo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universidade de sao paulo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universidade De Sao Paulo Today - Breaking & Trending Today

Vitamin D Flops in Moderate-Severe COVID

email article
Among patients with moderate to severe COVID-19, there was no difference in length of hospital stay in those given a single 200,000-IU dose of vitamin D
3 versus those given placebo in a randomized trial in Brazil.
Median length of hospital stay was about 7 days for both groups, with no significant differences in secondary outcomes including in-hospital mortality, admission to ICU, or need for mechanical ventilation, reported Rosa Pereira, MD, PhD, of Universidade de Sao Paulo, and colleagues in an online edition of
An accompanying editorial by David Leaf, MD, of Brigham and Women s Hospital in Boston, and Adit Ginde, MD, MPH, of University of Colorado School of Medicine in Aurora, noted that prior research showed that lower levels of vitamin D were independently associated with worse outcomes in patients with acute illness, but also that vitamin D supplementation as a treatment had no impact on clinical outcomes. ....

United States , Sao Paulo , Molly Walker , David Leaf , Rosa Pereira , University Of Colorado School Medicine , Universidade De Sao Paulo , Adit Ginde , Colorado School , Common Cold , Influenza Like Illness , Disorder Of Respiratory System , ஒன்றுபட்டது மாநிலங்களில் , ஸ்ம் பாலொ , மாலீ வாக்கர் , டேவிட் இலை , ரோசா பெரேரா , பல்கலைக்கழகம் ஆஃப் கொலராடோ பள்ளி மருந்து , யுனிவர்சிடேட் டி ஸ்ம் பாலொ , கொலராடோ பள்ளி , பொதுவானது குளிர் , கோளாறு ஆஃப் சுவாச அமைப்பு ,

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

Sao Paulo , Cibele Russo , Cleuber Esteves Chaves , Monica Pinheiro , Msc Ibirapuera , Mayara Diniz Santos , Rosa Maria Rodrigues Pereira , Sao Paulo Research Foundation , Phd University Of Sao Paulo , Rheumatology Division , Clinical Hospital , Study Interventions , Hoc Analyses , Faculdade De Medicina , Universidade De Sao Paulo , Interest Disclosures , Conselho Nacional De Desenvolvimento Cient , Sharing Statement , Roberta Costa , Albert Einstein Hospital , ஸ்ம் பாலொ , ரோசா மரியா ரோட்ரிகஸ் பெரேரா , ஸ்ம் பாலொ ஆராய்ச்சி அடித்தளம் , வாத நோய் பிரிவு , மருத்துவ மருத்துவமனை , படிப்பு தலையீடுகள் ,

Lung ultrasound may help predict Covid patient outcomes

Lung ultrasound, considered a simple method for diagnosing lung disease, can also help predict the clinical progression of severe Covid-19 patients, a new study suggests.The study, published in the journal Annals of Intensive Care, showed that . ....

Sao Paulo , Intensive Care , Heraldo Possolo De Souza , Universidade De Sao Paulo , ஸ்ம் பாலொ , தீவிர பராமரிப்பு , யுனிவர்சிடேட் டி ஸ்ம் பாலொ ,

Herd immunity inference from Delhi's serosurvey to be taken with pinch of salt, say scientists

Herd immunity inference from Delhi s serosurvey to be taken with pinch of salt, say scientists
Latest sero survey shows 56.13 per cent of people in the Delhi have antibodies against Covid but scientists are wary.
Share Via Email
| A+A A-
A woman wearing a protective mask to help curb the spread of the coronavirus walks in front of social distancing notice. (Photo | AP)
By PTI
NEW DELHI: Has Delhi achieved herd immunity against COVID-19? It is tempting to say yes given the dipping case count assessed in tandem with the latest sero survey that shows 56.13 per cent of people in the city have antibodies against the infection but scientists are wary. ....

Anthony Fauci , Joe Biden , Satyender Jain , Satish Devadas , Satyajit Rath , Ramanan Laxminarayan , Vineeta Bal , Michelc Nussenzweig , Rockefeller University , Indian Institute Of Science Education , Delhi National Institute Of Immunology , Institute Of Life Sciences In Odisha , Khas Delhi , South West Delhi , North Delhi , Minister Satyender Jain , Life Sciences , Disease Dynamics , Universidade De Sao Paulo , New Delhi , National Institute , Indian Institute , Science Education , ஓஹோ பிடென் , சாடயெண்தேர் ஜெயின் , சத்தீஷ் தேவதாஸ் ,

Take herd immunity sign from Delhi serosurvey with a pinch of salt: Experts

Has Delhi achieved herd immunity against COVID-19? It is tempting to say yes given the dipping case count assessed in tandem with the latest sero survey that shows 56.13 per cent of people in the city have antibodies against the infection but scientists are wary.
On Tuesday, the Delhi government announced the results of the fifth sero survey, with a sample of 28,000 across 11 districts in Delhi. The score of 56.13 per cent seroprevalence with Southwest Delhi highest at 62.18 per cent and North Delhi lowest at 49.09 per cent indicates perhaps that the national capital could be the first in the country to achieve herd immunity. ....

Anthony Fauci , Joe Biden , Satyender Jain , Satish Devadas , Satyajit Rath , Ramanan Laxminarayan , Vineeta Bal , Michelc Nussenzweig , Rockefeller University , Indian Institute Of Science Education , Delhi National Institute Of Immunology , Institute Of Life Sciences In Odisha , Khas Delhi , South West Delhi , North Delhi , Minister Satyender Jain , Life Sciences , Disease Dynamics , Universidade De Sao Paulo , New Delhi , National Institute , Indian Institute , Science Education , ஓஹோ பிடென் , சாடயெண்தேர் ஜெயின் , சத்தீஷ் தேவதாஸ் ,